February 16, 2015
The former head of Johnson & Johnson's ($JNJ) initiative to develop stratified drugs for Alzheimer's disease is trying to...
Orion CEO Magali Haas Featured in Partnering for Cures panel: Unlocking the Mysteries of the Human BrainNovember 25, 2014
What if we started diagnosing brain disorders based on physiological measures as opposed to the behavioral measures that are…
Orion Alliance Leadership Member Philip De Jager, MD, PhD, Awarded the National MS Society’s 2014 Barancik Prize for Innovation in MS ResearchOctober 23, 2014
Philip L. De Jager, MD, PhD, Neurologist at Brigham and Women’s Hospital and Associate Professor of Neurology at Harvard…
Orion CEO Co-Authors 2014 Report on the Milestones for the US National Plan to Address Alzheimer’s DiseaseOctober 20, 2014
Orion CEO & Founder Magali Haas was a co-author of the Alzheimer’s Association 2014 Report on the Milestones for...
September 29, 2014
Orion Bionetworks founder Magali Haas was quoted in this article about financing for the study of neurological disorders.
August 14, 2014
Dr. Iya Khalil, Co-founder and Executive VP of GNS Healthcare (an Orion Bionetworks Partner), was featured in PharmaVOICE July/August...
April 22, 2014
Orion’s pilot project to understand the complex human experience of MS with powerful computers is at the early stage…
October 30, 2013
In MS, genetics, environment, and hundreds of other factors come together to elicit the immune system attack on neurons…
October 22, 2013
Thomson Reuters Collaborates with Orion Bionetworks to Advance the Understanding of Multiple Sclerosis Alliance to develop predictive disease models...
July 2, 2013
Rancho BioSciences is helping the Accelerated Cure Project by curating and preparing diverse data sets coming in from researchers…